HK1028347A1 - Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity - Google Patents

Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity

Info

Publication number
HK1028347A1
HK1028347A1 HK00107849A HK00107849A HK1028347A1 HK 1028347 A1 HK1028347 A1 HK 1028347A1 HK 00107849 A HK00107849 A HK 00107849A HK 00107849 A HK00107849 A HK 00107849A HK 1028347 A1 HK1028347 A1 HK 1028347A1
Authority
HK
Hong Kong
Prior art keywords
antiviral
pharmaceutical
glycyrrhizic acid
composition
antiviral activity
Prior art date
Application number
HK00107849A
Other languages
English (en)
Inventor
Raffaello Pompei
Mario Pinza
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1028347A1 publication Critical patent/HK1028347A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
HK00107849A 1997-05-14 2000-12-07 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity HK1028347A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001119A IT1291366B1 (it) 1997-05-14 1997-05-14 Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
PCT/EP1998/002797 WO1998051334A1 (en) 1997-05-14 1998-05-06 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity

Publications (1)

Publication Number Publication Date
HK1028347A1 true HK1028347A1 (en) 2001-02-16

Family

ID=11377123

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00107849A HK1028347A1 (en) 1997-05-14 2000-12-07 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity

Country Status (27)

Country Link
US (1) US6329339B1 (ru)
EP (1) EP0980254B1 (ru)
JP (2) JP2001525814A (ru)
KR (1) KR100592193B1 (ru)
CN (1) CN1114447C (ru)
AR (1) AR012849A1 (ru)
AT (1) ATE212232T1 (ru)
AU (1) AU740944B2 (ru)
BG (1) BG64748B1 (ru)
CA (1) CA2289550A1 (ru)
CZ (1) CZ291932B6 (ru)
DE (1) DE69803565T2 (ru)
DK (1) DK0980254T3 (ru)
EA (1) EA003126B1 (ru)
ES (1) ES2170501T3 (ru)
GE (1) GEP20022672B (ru)
HK (1) HK1028347A1 (ru)
HU (1) HU224956B1 (ru)
IL (2) IL132651A0 (ru)
IT (1) IT1291366B1 (ru)
PL (1) PL189218B1 (ru)
PT (1) PT980254E (ru)
SK (1) SK283584B6 (ru)
TR (1) TR199902730T2 (ru)
UA (1) UA63955C2 (ru)
WO (1) WO1998051334A1 (ru)
ZA (1) ZA983917B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
AU2003225073A1 (en) * 2002-04-18 2003-11-03 The University Of Iowa Research Foundation Methods of inhibiting and treating bacterial biofilms by metal chelators
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
CA2538763C (en) * 2003-09-11 2015-05-05 Critical Therapeutics, Inc. Monoclonal antibodies against hmgb1
US20100040608A1 (en) * 2005-07-18 2010-02-18 Marie Wahren-Herlenius Use of HMGB1 antagonists for the treatment of inflammatory skin conditions
US20080311122A1 (en) * 2005-11-28 2008-12-18 Medimmune, Llc Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof
IT1391170B1 (it) * 2008-08-07 2011-11-18 D M G Italia S R L Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale
WO2012026928A1 (en) * 2010-08-25 2012-03-01 Diacarta Llc Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
US9416151B2 (en) 2010-08-25 2016-08-16 Lurong ZHANG Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
JP5806434B1 (ja) * 2014-02-21 2015-11-10 国立大学法人東京海洋大学 ノロウィルス不活化剤及びその製造方法、ノロウィルス不活化方法、ノロウィルス不活化用リゾチーム類の製造方法、ノロウィルス感染の予防薬又は治療薬、並びにノロウィルス不活化用皮膚外用剤
US20170246262A1 (en) 2016-02-25 2017-08-31 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
CN109022351B (zh) * 2018-09-28 2021-10-19 广州奇龙生物科技有限公司 重组人溶菌酶的新应用
US20220305092A1 (en) * 2020-04-27 2022-09-29 Guangzhou Century Clinical Research Co., Ltd Medicament and food for preventing or treating novel coronavirus pneumonia covid-19 and use thereof
CN112135625B (zh) * 2020-04-27 2021-07-06 广州新创忆药物临床研究有限公司 一种预防或治疗covid-19新冠肺炎的药物及其应用
US20230158124A1 (en) * 2020-04-27 2023-05-25 Guangzhou Century Clinical Research Co., Ltd Drug, food and application of anti-coronavirus infection
MX2021005280A (es) * 2021-05-04 2022-02-23 Spv Timser S A P I De C V Composicion farmaceutica que contiene triterpenoides pentaciclicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085800B2 (ja) * 1986-12-19 1996-01-24 エーザイ株式会社 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
JP2838720B2 (ja) * 1989-10-31 1998-12-16 ゼリア新薬工業株式会社 安定な点眼剤
JP4056099B2 (ja) * 1996-05-09 2008-03-05 森永乳業株式会社 水生動物の寄生生物性疾患の予防および治療剤

Also Published As

Publication number Publication date
EP0980254B1 (en) 2002-01-23
GEP20022672B (en) 2002-04-25
EA003126B1 (ru) 2003-02-27
AU740944B2 (en) 2001-11-15
PL336802A1 (en) 2000-07-17
UA63955C2 (ru) 2004-02-16
US6329339B1 (en) 2001-12-11
WO1998051334A1 (en) 1998-11-19
SK283584B6 (sk) 2003-10-07
DE69803565T2 (de) 2002-08-08
CN1114447C (zh) 2003-07-16
DE69803565D1 (de) 2002-03-14
CZ399199A3 (cs) 2000-04-12
KR20010012419A (ko) 2001-02-15
ATE212232T1 (de) 2002-02-15
IT1291366B1 (it) 1999-01-07
AU7764698A (en) 1998-12-08
AR012849A1 (es) 2000-11-22
TR199902730T2 (xx) 2000-02-21
HU224956B1 (en) 2006-04-28
PT980254E (pt) 2002-07-31
SK154499A3 (en) 2000-08-14
PL189218B1 (pl) 2005-07-29
KR100592193B1 (ko) 2006-06-23
IL132651A0 (en) 2001-03-19
ZA983917B (en) 1998-11-09
CA2289550A1 (en) 1998-11-19
JP2001525814A (ja) 2001-12-11
ES2170501T3 (es) 2002-08-01
HUP0002985A3 (en) 2001-04-28
JP2009102370A (ja) 2009-05-14
EP0980254A1 (en) 2000-02-23
ITMI971119A1 (it) 1998-11-14
HUP0002985A2 (hu) 2001-01-29
CZ291932B6 (cs) 2003-06-18
CN1255859A (zh) 2000-06-07
BG64748B1 (bg) 2006-02-28
EA199901024A1 (ru) 2000-06-26
IL132651A (en) 2006-10-31
BG103968A (en) 2000-07-31
DK0980254T3 (da) 2002-05-06
ITMI971119A0 (ru) 1997-05-14

Similar Documents

Publication Publication Date Title
HUP0002985A3 (en) Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
DE69828512D1 (de) Granulierter plasmaproteinfutterzusatz mit erhöhter biowirksamkeit
EP1024130A4 (en) BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE
EP0950665A4 (en) PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
ZA985352B (en) Barbituric acid derivatives with antimetastatic and antitumor activity.
IL128144A0 (en) Benzamidine derivatives and their use as medicaments with an ltb4-antagonistic activity
HUP0105105A3 (en) Macrolides with anti-inflammatory activity and medicaments containing them
IL126247A0 (en) Novel imidazolidine derivatives their preparation their use and pharmaceutical preparations comprising them
HU9701080D0 (en) Pharmaceutical composition of antiviral activity
IT1291353B1 (it) Peptidi con attivita' antivirale
ZA9811655B (en) Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same
HUP0003189A2 (en) Pharmaceutical composition comprising fexofenadine and its derivatives
ZA986756B (en) Modified polypeptides with high activity and reduced allergenicity
DE69833460D1 (de) Rekombinantes allergen mit reduzierter enzymatischer aktivität
ZA987633B (en) Dried biologically or therapeutically active preparations
AU8168898A (en) Interferon stimulating protein and uses thereof
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
SI0980254T1 (en) Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
AU1821300A (en) Peptides having anti-cancer and anti-inflammatory activity
EP0692537A3 (en) Recombinant gibberellin DNA and its use
AU8526198A (en) Compounds with anti-ks and anti-hiv activity
HUP9901165A3 (en) Thiamorphinans with neuroprotective activity, pharmaceutical compositions and use of the same
KR0185794B1 (en) Pharmaceutical preparations having anti-fibrotic activity
ZA977043B (en) Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
GB9725149D0 (en) Insecticidal gene and peptide

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090506